Výsledky vyhledávání - "Christine Folz"

Safety and Efficacy of the CD95-Ligand Inhibitor APG101 in Transfusion-Dependent Patients with Low Risk MDS: Results from a Phase I Study

Autor: Wolf-Karsten Hofmann, Daniel Nowak, Harald Fricke, Johann-Christoph Jann, Christine Folz, Susanne Brendel, Jennifer Klemmer, Claudia Kunz, Thomas Luft, Maximilian Mossner, Florian Nolte, Tobias Boch

Publikováno v: ResearcherID

Introduction:Particularly in low risk MDS, a pro-apoptotic milieu has been described with increased levels of apoptosis-promoting factors such as tumor necrosis factor and fas ligand (CD95 ligand). Evidence exists that in low risk MDS increased apopt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4fa14a914c8336b0866af773a3ebfc
https://doi.org/10.1182/blood.v128.22.228.228

Zobrazit plný text záznamu

Safety and efficacy of the CD95-ligand inhibitor APG101 in transfusion-dependent patients with low risk MDS: Interim results from a phase I study

Autor: Thomas Luft, Anthony D. Ho, Daniel Nowak, Christine Folz, Florian Nolte, Tobias Boch, Max Mossner, Jennifer Klemmer, Johann Christoph Jann, Harald Fricke, Claudia Kunz, Wolf-Karsten Hofmann, Susanne Brendel

Publikováno v: Journal of Clinical Oncology. 34:e18552-e18552

e18552Background: Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis resulting in peripheral cytopenia. In low risk MDS, a pro-apoptotic milieu was found with increased ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d05b223f6a46c3f682e7c74bd9e9061b
https://doi.org/10.1200/jco.2016.34.15_suppl.e18552

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání